Arvin AM - Search Results

1

Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.

Koropchak CM, Solem SM, Diaz PS, Arvin AM. Koropchak CM, et al. Among authors: arvin am. J Virol. 1989 May;63(5):2392-5. doi: 10.1128/JVI.63.5.2392-2395.1989. J Virol. 1989. PMID: 2539528 Free PMC article.

2

The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.

Kinchington PR, Hougland JK, Arvin AM, Ruyechan WT, Hay J. Kinchington PR, et al. Among authors: arvin am. J Virol. 1992 Jan;66(1):359-66. doi: 10.1128/JVI.66.1.359-366.1992. J Virol. 1992. PMID: 1309252 Free PMC article.

3

Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.

Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Wilson A, et al. Among authors: arvin am. J Infect Dis. 1992 Jan;165(1):119-26. doi: 10.1093/infdis/165.1.119. J Infect Dis. 1992. PMID: 1309369

4

Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.

Koropchak CM, Graham G, Palmer J, Winsberg M, Ting SF, Wallace M, Prober CG, Arvin AM. Koropchak CM, et al. Among authors: arvin am. J Infect Dis. 1992 Jan;165(1):188. J Infect Dis. 1992. PMID: 1309373 No abstract available.

5

Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.

Sharp M, Terada K, Wilson A, Nader S, Kinchington PE, Ruyechan WT, Hay J, Arvin AM. Sharp M, et al. Among authors: arvin am. J Infect Dis. 1992 May;165(5):852-8. doi: 10.1093/infdis/165.5.852. J Infect Dis. 1992. PMID: 1314871 Clinical Trial.

6

Cell-mediated immunity to varicella-zoster virus.

Arvin AM. Arvin AM. J Infect Dis. 1992 Aug;166 Suppl 1:S35-41. doi: 10.1093/infdis/166.supplement_1.s35. J Infect Dis. 1992. PMID: 1320649 Review.

7

Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.

Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM. Lowry PW, et al. Among authors: arvin am. J Gen Virol. 1992 Apr;73 ( Pt 4):811-9. doi: 10.1099/0022-1317-73-4-811. J Gen Virol. 1992. PMID: 1321876

8

Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.

Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J. Arvin AM, et al. J Immunol. 1991 Jan 1;146(1):257-64. J Immunol. 1991. PMID: 1670603

9

Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.

Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Bergen RE, et al. Among authors: arvin am. Viral Immunol. 1991 Fall;4(3):151-66. doi: 10.1089/vim.1991.4.151. Viral Immunol. 1991. PMID: 1725699

10

Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.

Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM. Diaz PS, et al. Among authors: arvin am. Pediatrics. 1991 Feb;87(2):166-70. Pediatrics. 1991. PMID: 1846236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters